Erratum: Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (Cell (2021) 184(21) (5309–5337), (S0092867421011016), (10.1016/j.cell.2021.09.020))

Golnaz Morad, Beth A. Helmink, Padmanee Sharma, Jennifer A. Wargo

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

(Cell 184, 5309–5337; October 14, 2021) We have identified errors in Table 1 of the originally published version of this review. During preparation of Table 1, we mistakenly listed the all-cause event rate, rather than the indicated high-grade (3-5) treatment-related adverse event rate, for KEYNOTE-189/NCT02578680 and KEYNOTE-407/NCT02775435. Table 1 and references (PMIDs) related to the final reports of KEYNOTE-189/NCT02578680 and KEYNOTE-407/NCT02775435, which include treatment-related adverse event rates, have now been corrected online. The authors apologize for any confusion these errors may have caused.

Original languageEnglish
Pages (from-to)576
Number of pages1
JournalCell
Volume185
Issue number3
DOIs
StatePublished - Feb 3 2022

Fingerprint

Dive into the research topics of 'Erratum: Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (Cell (2021) 184(21) (5309–5337), (S0092867421011016), (10.1016/j.cell.2021.09.020))'. Together they form a unique fingerprint.

Cite this